BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37724405)

  • 1. Clinical efficacy of protein A immunoadsorption therapy on severe ANCA-associated vasculitis renal injury.
    Song J; Liu H; Chen X; Zhou L; Sun C; Yuan F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1026-1032. PubMed ID: 37724405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of protein A immunoadsorption and therapeutic plasma exchange in ANCA-associated vasculitis with severe renal involvement: a retrospective study.
    Liu X; Xia M; Liu D; Liu H; Tang C; Chen G; Liu Y; Yuan F; Liu H
    Ann Med; 2023 Dec; 55(1):2230875. PubMed ID: 37452682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement.
    Chu X; Hong Y; Wang Y; Yu C; Wang L; Tong H; Yan J; Zhang Z; Xu G; Yao Y; Zeng R
    Am J Nephrol; 2021; 52(12):899-908. PubMed ID: 34875652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
    Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA;
    Arthritis Rheumatol; 2019 Jun; 71(6):952-963. PubMed ID: 30666823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.
    Mosakowska M; Kania DB; Szamotulska K; Rymarz A; Niemczyk S
    BMC Nephrol; 2021 Aug; 22(1):290. PubMed ID: 34445984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis.
    Huang L; Zhong Y; Ooi JD; Zhou YO; Zuo X; Luo H; Chen JB; Wu T; Yang Y; Meng T; Xiao Z; Lin W; Ao X; Xiao X; Zhou Q; Xiao P
    Int Immunopharmacol; 2019 Nov; 76():105883. PubMed ID: 31536905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series.
    Caroti L; Cirami CL; Di Maria L; Larti A; Carta P; Dervishi E; Farsetti S; Tsalouchos A; Novelli L; Minetti EE
    BMC Nephrol; 2019 May; 20(1):162. PubMed ID: 31088509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
    Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Prognosis in ANCA Associated Vasculitis Patients with Acute Kidney Injury.
    Chen Y; Lu Y; Zhou Y; Yu C
    Arch Iran Med; 2022 Apr; 25(4):235-240. PubMed ID: 35942995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary isomorphic red blood cells for the prediction of disease severity and renal outcomes in MPO-ANCA-associated vasculitis: a retrospective cohort study.
    Wang F; Jin Y; Zhou F; Luo L; Tang J; Huang L; Hu X; Liao Z; Jiang Y; Dengshuang L; Ge H; Sun D; Xiao G; Feng J; Li X
    J Nephrol; 2023 Nov; 36(8):2295-2304. PubMed ID: 37395920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of superoxide dismutase: clinical usefulness for patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Zhang Z; Huang W; Ren F; Luo L; Zhou J; Tang L
    Adv Rheumatol; 2023 Jun; 63(1):28. PubMed ID: 37381048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
    Bulanov NM; Makarov EA; Shchegoleva EM; Zykova AS; Vinogradova ES; Novikov PI; Lysenko Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2018 Jun; 90(6):15-21. PubMed ID: 30701899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.